Skip Navigation

Phone Service Update

We are experiencing extremely high call volume related to COVID-19 vaccine interest. Please understand that our phone lines must be clear for people with urgent and acute medical care needs. Unfortunately, this means we are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this web site. Read more COVID-19 Vaccine Information

Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts

How to Apply & FAQs

Heme and Med Oncology Fellows indoor group

Q: How are you handling fellowship applications this season? 

A: Due to the COVID-19 pandemic, the fellowship application process this year will be conducted virtually. Applications are due to the electronic residency application service (ERAS) by August 12, 2020. 

We will review all applications and issue interview invites by mid September. Interviews will be conducted virtually on select dates in October. 

We understand this is not the traditional, in-person experience that fellowship candidates generally count on, and our proud of our facilities and campus. However, we will do our best to allow candidates to gain as much knowledge about our program as possible in a virtual manner while protecting everyone’s health and safety.

Explore our detailed application process

Meet our current fellows.

See and learn more about our buildings/facilities.

Q: What types of tracks or boarding do you offer?

A: We have a flexible training program that allows fellows to pursue boarding in either medical oncology, hematology, or both. Fellows interested in studying hematologic malignancies can do so through either track. Fellows can also choose to double board regardless of their career interests. After completing the first year, fellows can choose to enter into two years of mentored academic research training or extend their clinical training by an additional six months to receive dual certification, followed by 18 months of research training. 

Heme and Med Oncology Fellows in group with white lab coats.

Q: What impact has COVID-19 had on fellowship training this year?

A: Johns Hopkins Medicine has taken great precautions to keep our patients, employees and trainees safe and protected during the COVID-19 pandemic, implementing quick use of personal protective equipment, dedicated inpatient units for COVID-positive patients and social distancing wherever possible. We have a dedicated coronavirus website featuring information about the virus, our expertise, and news about our innovative efforts to manage patients and conduct research into potential screening tests and treatments. The state of Maryland also implemented a number of steps to reduce transmission, such as closing schools and encouraging teleworking. 

Our hematology and oncology rotations have continued as planned. Fellows have retained their fellow-specific duties and apart from minor adjustments to workflow, have continued working on dedicated hematology-oncology services caring for COVID-negative patients. The Kimmel Cancer Center inpatient units are in a separate building from the main hospital and have not had COVID-positive patients. On the outpatient side, we have incorporated telemedicine visits with patients, and virtual tumor boards, case conferences and educational activities. As of June, these activities slowly and safely are starting to resume as in-person events. 

We have taken every precaution to ensure that every clinic follows guidelines established by not only our own experts, but those of the CDC regarding COVID-19, including:

•    Screening and, if needed, testing our patients and staff members for coronavirus
•    Requiring universal masking and wearing appropriate protective equipment 
•    Limiting the number of people at each facility and practicing social distancing 
•    Keeping our facilities clean: Surfaces and equipment in all exam, treatment and waiting rooms are cleaned with extra frequency and detail. 
•    Maintaining outstanding hand hygiene: Hand sanitizer is always available, and our doctors, nurses and all medical staff members sanitize or wash their hands before and after interacting with every patient. 

Q: What impact has COVID-19 had on research operations?

A: Clinical trial operations and non-essential research were paused during the peak months of April and May, just as in many other academic medical centers across the country. As of June, Johns Hopkins has been slowly starting to open labs again for research purposes, with precautions in place such as wearing masks and having no more than two people share an elevator at one time.

Q: What is your commitment to diversity?

A: Johns Hopkins Medicine attracts employees and trainees from many cultures and ethnicities worldwide, and is proud to uphold the values of respect, dignity, integrity, inclusion, excellence and diversity. The Office of Diversity, Inclusion and Health Equity provides our community information on cultural events, religious and spiritual observations that may be relevant to employees and patients throughout Johns Hopkins Medicine, and is drafting a diversity, inclusion and health equity strategic action plan to be rolled out starting in fiscal year 2021. On June 5, staff members from throughout our community gathered to take a knee in solidarity with the Johns Hopkins House Staff Diversity Council and White Coats for Black Lives, a national organization founded by medical students. Johns Hopkins Medicine also participates in Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ) Pride Month events and celebrations in Baltimore; Washington, D.C.; Howard County, Md.; Annapolis, Md.; and St. Petersburg, Fla. We are continuously working to improve diversity in patient participation in clinical trials as well as in our workforce. 

Q: Do you offer visas for non-U.S. citizens? 

A: For non-U.S. citizens, we offer J1 exchange visitor visas. However, the university is unable to routinely sponsor H1B visas. 

back to top button